🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-524852-74-00
Authorised Phase I

A clinical trial of MK-3214 taken with different liquids in healthy participants (MK-3214-002)

2025-524852-74-00 · tracked via the Priya Life Science EU tracker
Sponsor
Merck Sharp & Dohme LLC
Sponsor type
Pharmaceutical company
Therapeutic area
Cardiovascular Diseases
Decision date
06/03/2026
Enrollment target
32
Sites
Belgium

Condition studied

Hypercholesterolaemia

Eligibility

Age group
18-64 years
Sex
Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-524852-74-00 on CTIS ↗ ← All trials in the EU